img

Global Non-opioid Analgesics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Non-opioid Analgesics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Non-opioid Analgesics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-opioid Analgesics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Non-opioid Analgesics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-opioid Analgesics key manufacturers include AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Centrexion Therapeutics, Cara Therapeutics and Medropharm GmbH., etc. AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd. are top 3 players and held % sales share in total in 2022.
Non-opioid Analgesics can be divided into NSAIDs, Acetaminophen and Local Anesthetics,, etc. NSAIDs is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-opioid Analgesics is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Non-opioid Analgesics industry development. In 2022, global % sales of Non-opioid Analgesics went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Analgesics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie Inc
Pfizer, Inc
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Centrexion Therapeutics
Cara Therapeutics
Medropharm GmbH.
Segment by Type
NSAIDs
Acetaminophen
Local Anesthetics

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-opioid Analgesics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-opioid Analgesics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-opioid Analgesics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Non-opioid Analgesics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-opioid Analgesics introduction, etc. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Non-opioid Analgesics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Non-opioid Analgesics Market Overview
1.1 Non-opioid Analgesics Product Overview
1.2 Non-opioid Analgesics Market Segment by Type
1.2.1 NSAIDs
1.2.2 Acetaminophen
1.2.3 Local Anesthetics
1.3 Global Non-opioid Analgesics Market Size by Type
1.3.1 Global Non-opioid Analgesics Market Size Overview by Type (2024-2034)
1.3.2 Global Non-opioid Analgesics Historic Market Size Review by Type (2024-2024)
1.3.3 Global Non-opioid Analgesics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non-opioid Analgesics Sales Breakdown by Type (2024-2024)
1.4.2 Europe Non-opioid Analgesics Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Non-opioid Analgesics Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Non-opioid Analgesics Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Non-opioid Analgesics Sales Breakdown by Type (2024-2024)
2 Global Non-opioid Analgesics Market Competition by Company
2.1 Global Top Players by Non-opioid Analgesics Sales (2024-2024)
2.2 Global Top Players by Non-opioid Analgesics Revenue (2024-2024)
2.3 Global Top Players by Non-opioid Analgesics Price (2024-2024)
2.4 Global Top Manufacturers Non-opioid Analgesics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-opioid Analgesics Market Competitive Situation and Trends
2.5.1 Non-opioid Analgesics Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Non-opioid Analgesics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-opioid Analgesics as of 2022)
2.7 Date of Key Manufacturers Enter into Non-opioid Analgesics Market
2.8 Key Manufacturers Non-opioid Analgesics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non-opioid Analgesics Status and Outlook by Region
3.1 Global Non-opioid Analgesics Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Non-opioid Analgesics Historic Market Size by Region
3.2.1 Global Non-opioid Analgesics Sales in Volume by Region (2024-2024)
3.2.2 Global Non-opioid Analgesics Sales in Value by Region (2024-2024)
3.2.3 Global Non-opioid Analgesics Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Non-opioid Analgesics Forecasted Market Size by Region
3.3.1 Global Non-opioid Analgesics Sales in Volume by Region (2024-2034)
3.3.2 Global Non-opioid Analgesics Sales in Value by Region (2024-2034)
3.3.3 Global Non-opioid Analgesics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Non-opioid Analgesics by Application
4.1 Non-opioid Analgesics Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Non-opioid Analgesics Market Size by Application
4.2.1 Global Non-opioid Analgesics Market Size Overview by Application (2024-2034)
4.2.2 Global Non-opioid Analgesics Historic Market Size Review by Application (2024-2024)
4.2.3 Global Non-opioid Analgesics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non-opioid Analgesics Sales Breakdown by Application (2024-2024)
4.3.2 Europe Non-opioid Analgesics Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Non-opioid Analgesics Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Non-opioid Analgesics Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Non-opioid Analgesics Sales Breakdown by Application (2024-2024)
5 North America Non-opioid Analgesics by Country
5.1 North America Non-opioid Analgesics Historic Market Size by Country
5.1.1 North America Non-opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Non-opioid Analgesics Sales in Volume by Country (2024-2024)
5.1.3 North America Non-opioid Analgesics Sales in Value by Country (2024-2024)
5.2 North America Non-opioid Analgesics Forecasted Market Size by Country
5.2.1 North America Non-opioid Analgesics Sales in Volume by Country (2024-2034)
5.2.2 North America Non-opioid Analgesics Sales in Value by Country (2024-2034)
6 Europe Non-opioid Analgesics by Country
6.1 Europe Non-opioid Analgesics Historic Market Size by Country
6.1.1 Europe Non-opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Non-opioid Analgesics Sales in Volume by Country (2024-2024)
6.1.3 Europe Non-opioid Analgesics Sales in Value by Country (2024-2024)
6.2 Europe Non-opioid Analgesics Forecasted Market Size by Country
6.2.1 Europe Non-opioid Analgesics Sales in Volume by Country (2024-2034)
6.2.2 Europe Non-opioid Analgesics Sales in Value by Country (2024-2034)
7 Asia-Pacific Non-opioid Analgesics by Region
7.1 Asia-Pacific Non-opioid Analgesics Historic Market Size by Region
7.1.1 Asia-Pacific Non-opioid Analgesics Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Non-opioid Analgesics Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Non-opioid Analgesics Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Non-opioid Analgesics Forecasted Market Size by Region
7.2.1 Asia-Pacific Non-opioid Analgesics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Non-opioid Analgesics Sales in Value by Region (2024-2034)
8 Latin America Non-opioid Analgesics by Country
8.1 Latin America Non-opioid Analgesics Historic Market Size by Country
8.1.1 Latin America Non-opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Non-opioid Analgesics Sales in Volume by Country (2024-2024)
8.1.3 Latin America Non-opioid Analgesics Sales in Value by Country (2024-2024)
8.2 Latin America Non-opioid Analgesics Forecasted Market Size by Country
8.2.1 Latin America Non-opioid Analgesics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Non-opioid Analgesics Sales in Value by Country (2024-2034)
9 Middle East and Africa Non-opioid Analgesics by Country
9.1 Middle East and Africa Non-opioid Analgesics Historic Market Size by Country
9.1.1 Middle East and Africa Non-opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Non-opioid Analgesics Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Non-opioid Analgesics Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Non-opioid Analgesics Forecasted Market Size by Country
9.2.1 Middle East and Africa Non-opioid Analgesics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Non-opioid Analgesics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie Inc
10.1.1 AbbVie Inc Company Information
10.1.2 AbbVie Inc Introduction and Business Overview
10.1.3 AbbVie Inc Non-opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.1.4 AbbVie Inc Non-opioid Analgesics Products Offered
10.1.5 AbbVie Inc Recent Development
10.2 Pfizer, Inc
10.2.1 Pfizer, Inc Company Information
10.2.2 Pfizer, Inc Introduction and Business Overview
10.2.3 Pfizer, Inc Non-opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Pfizer, Inc Non-opioid Analgesics Products Offered
10.2.5 Pfizer, Inc Recent Development
10.3 Teva Pharmaceutical Industries Ltd.
10.3.1 Teva Pharmaceutical Industries Ltd. Company Information
10.3.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
10.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Products Offered
10.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.4 Viatris Inc.
10.4.1 Viatris Inc. Company Information
10.4.2 Viatris Inc. Introduction and Business Overview
10.4.3 Viatris Inc. Non-opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Viatris Inc. Non-opioid Analgesics Products Offered
10.4.5 Viatris Inc. Recent Development
10.5 Centrexion Therapeutics
10.5.1 Centrexion Therapeutics Company Information
10.5.2 Centrexion Therapeutics Introduction and Business Overview
10.5.3 Centrexion Therapeutics Non-opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Centrexion Therapeutics Non-opioid Analgesics Products Offered
10.5.5 Centrexion Therapeutics Recent Development
10.6 Cara Therapeutics
10.6.1 Cara Therapeutics Company Information
10.6.2 Cara Therapeutics Introduction and Business Overview
10.6.3 Cara Therapeutics Non-opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Cara Therapeutics Non-opioid Analgesics Products Offered
10.6.5 Cara Therapeutics Recent Development
10.7 Medropharm GmbH.
10.7.1 Medropharm GmbH. Company Information
10.7.2 Medropharm GmbH. Introduction and Business Overview
10.7.3 Medropharm GmbH. Non-opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Medropharm GmbH. Non-opioid Analgesics Products Offered
10.7.5 Medropharm GmbH. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non-opioid Analgesics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non-opioid Analgesics Industrial Chain Analysis
11.4 Non-opioid Analgesics Market Dynamics
11.4.1 Non-opioid Analgesics Industry Trends
11.4.2 Non-opioid Analgesics Market Drivers
11.4.3 Non-opioid Analgesics Market Challenges
11.4.4 Non-opioid Analgesics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non-opioid Analgesics Distributors
12.3 Non-opioid Analgesics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of NSAIDs
Table 2. Major Company of Acetaminophen
Table 3. Major Company of Local Anesthetics
Table 4. Global Non-opioid Analgesics Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Non-opioid Analgesics Sales by Type (2024-2024) & (K Units)
Table 6. Global Non-opioid Analgesics Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Non-opioid Analgesics Sales by Type (2024-2024) & (US& Million)
Table 8. Global Non-opioid Analgesics Market Share in Value by Type (2024-2024)
Table 9. Global Non-opioid Analgesics Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Non-opioid Analgesics Sales by Type (2024-2034) & (K Units)
Table 11. Global Non-opioid Analgesics Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Non-opioid Analgesics Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Non-opioid Analgesics Sales Market Share in Value by Type (2024-2034)
Table 14. Global Non-opioid Analgesics Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Non-opioid Analgesics Sales by Type (2024-2024) & (K Units)
Table 16. North America Non-opioid Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Non-opioid Analgesics Sales (K Units) by Type (2024-2024)
Table 18. Europe Non-opioid Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Non-opioid Analgesics Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Non-opioid Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Non-opioid Analgesics Sales (K Units) by Type (2024-2024)
Table 22. Latin America Non-opioid Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Non-opioid Analgesics Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Non-opioid Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Non-opioid Analgesics Sales by Company (2024-2024) & (K Units)
Table 26. Global Non-opioid Analgesics Sales Share by Company (2024-2024)
Table 27. Global Non-opioid Analgesics Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Non-opioid Analgesics Revenue Share by Company (2024-2024)
Table 29. Global Market Non-opioid Analgesics Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Non-opioid Analgesics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Non-opioid Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-opioid Analgesics as of 2022)
Table 33. Date of Key Manufacturers Enter into Non-opioid Analgesics Market
Table 34. Key Manufacturers Non-opioid Analgesics Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Non-opioid Analgesics Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Non-opioid Analgesics Sales by Region (2024-2024) & (K Units)
Table 38. Global Non-opioid Analgesics Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Non-opioid Analgesics Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Non-opioid Analgesics Sales Market Share in Value by Region (2024-2024)
Table 41. Global Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Non-opioid Analgesics Sales by Region (2024-2034) & (K Units)
Table 43. Global Non-opioid Analgesics Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Non-opioid Analgesics Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Non-opioid Analgesics Sales Market Share in Value by Region (2024-2034)
Table 46. Global Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Non-opioid Analgesics Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Non-opioid Analgesics Sales by Application (2024-2024) & (K Units)
Table 49. Global Non-opioid Analgesics Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Non-opioid Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Non-opioid Analgesics Sales Market Share in Value by Application (2024-2024)
Table 52. Global Non-opioid Analgesics Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Non-opioid Analgesics Sales by Application (2024-2034) & (K Units)
Table 54. Global Non-opioid Analgesics Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Non-opioid Analgesics Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Non-opioid Analgesics Sales Market Share in Value by Application (2024-2034)
Table 57. Global Non-opioid Analgesics Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Non-opioid Analgesics Sales by Application (2024-2024) (K Units)
Table 59. North America Non-opioid Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Non-opioid Analgesics Sales by Application (2024-2024) (K Units)
Table 61. Europe Non-opioid Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Non-opioid Analgesics Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Non-opioid Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Non-opioid Analgesics Sales by Application (2024-2024) (K Units)
Table 65. Latin America Non-opioid Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Non-opioid Analgesics Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Non-opioid Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Non-opioid Analgesics Sales by Country (2024-2024) & (K Units)
Table 69. North America Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Non-opioid Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Non-opioid Analgesics Sales Market Share in Value by Country (2024-2024)
Table 72. North America Non-opioid Analgesics Sales by Country (2024-2034) & (K Units)
Table 73. North America Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Non-opioid Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Non-opioid Analgesics Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Non-opioid Analgesics Sales by Country (2024-2024) & (K Units)
Table 77. Europe Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Non-opioid Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Non-opioid Analgesics Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Non-opioid Analgesics Sales by Country (2024-2034) & (K Units)
Table 81. Europe Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Non-opioid Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Non-opioid Analgesics Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Non-opioid Analgesics Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Non-opioid Analgesics Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Non-opioid Analgesics Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Non-opioid Analgesics Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Non-opioid Analgesics Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Non-opioid Analgesics Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Non-opioid Analgesics Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Non-opioid Analgesics Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Non-opioid Analgesics Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Non-opioid Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Non-opioid Analgesics Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Non-opioid Analgesics Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Non-opioid Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Non-opioid Analgesics Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Non-opioid Analgesics Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Non-opioid Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Non-opioid Analgesics Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Non-opioid Analgesics Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Non-opioid Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Non-opioid Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Non-opioid Analgesics Sales Market Share in Value by Country (2024-2034)
Table 108. AbbVie Inc Company Information
Table 109. AbbVie Inc Introduction and Business Overview
Table 110. AbbVie Inc Non-opioid Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. AbbVie Inc Non-opioid Analgesics Product
Table 112. AbbVie Inc Recent Development
Table 113. Pfizer, Inc Company Information
Table 114. Pfizer, Inc Introduction and Business Overview
Table 115. Pfizer, Inc Non-opioid Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Pfizer, Inc Non-opioid Analgesics Product
Table 117. Pfizer, Inc Recent Development
Table 118. Teva Pharmaceutical Industries Ltd. Company Information
Table 119. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 120. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product
Table 122. Teva Pharmaceutical Industries Ltd. Recent Development
Table 123. Viatris Inc. Company Information
Table 124. Viatris Inc. Introduction and Business Overview
Table 125. Viatris Inc. Non-opioid Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Viatris Inc. Non-opioid Analgesics Product
Table 127. Viatris Inc. Recent Development
Table 128. Centrexion Therapeutics Company Information
Table 129. Centrexion Therapeutics Introduction and Business Overview
Table 130. Centrexion Therapeutics Non-opioid Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Centrexion Therapeutics Non-opioid Analgesics Product
Table 132. Centrexion Therapeutics Recent Development
Table 133. Cara Therapeutics Company Information
Table 134. Cara Therapeutics Introduction and Business Overview
Table 135. Cara Therapeutics Non-opioid Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Cara Therapeutics Non-opioid Analgesics Product
Table 137. Cara Therapeutics Recent Development
Table 138. Medropharm GmbH. Company Information
Table 139. Medropharm GmbH. Introduction and Business Overview
Table 140. Medropharm GmbH. Non-opioid Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Medropharm GmbH. Non-opioid Analgesics Product
Table 142. Medropharm GmbH. Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Non-opioid Analgesics Market Trends
Table 146. Non-opioid Analgesics Market Drivers
Table 147. Non-opioid Analgesics Market Challenges
Table 148. Non-opioid Analgesics Market Restraints
Table 149. Non-opioid Analgesics Distributors List
Table 150. Non-opioid Analgesics Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-opioid Analgesics Product Picture
Figure 2. Global Non-opioid Analgesics Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Non-opioid Analgesics Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Non-opioid Analgesics Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of NSAIDs
Figure 6. Global NSAIDs Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Acetaminophen
Figure 8. Global Acetaminophen Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Local Anesthetics
Figure 10. Global Local Anesthetics Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Non-opioid Analgesics Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Non-opioid Analgesics Sales Market Share by Type in 2022 & 2034
Figure 13. North America Non-opioid Analgesics Sales Market Share in Volume by Type in 2022
Figure 14. North America Non-opioid Analgesics Sales Market Share in Value by Type in 2022
Figure 15. Europe Non-opioid Analgesics Sales Market Share in Volume by Type in 2022
Figure 16. Europe Non-opioid Analgesics Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Non-opioid Analgesics Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Non-opioid Analgesics Sales Market Share in Value by Type in 2022
Figure 19. Latin America Non-opioid Analgesics Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Non-opioid Analgesics Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Non-opioid Analgesics Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Non-opioid Analgesics Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-opioid Analgesics Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-opioid Analgesics Revenue in 2022
Figure 25. Non-opioid Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospital Pharmacies
Figure 27. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Retail Pharmacies
Figure 29. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Online Pharmacies
Figure 31. Global Online Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Non-opioid Analgesics Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Non-opioid Analgesics Sales Market Share by Application in 2022 & 2034
Figure 34. North America Non-opioid Analgesics Sales Market Share in Volume by Application in 2022
Figure 35. North America Non-opioid Analgesics Sales Market Share in Value by Application in 2022
Figure 36. Europe Non-opioid Analgesics Sales Market Share in Volume by Application in 2022
Figure 37. Europe Non-opioid Analgesics Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Non-opioid Analgesics Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Non-opioid Analgesics Sales Market Share in Value by Application in 2022
Figure 40. Latin America Non-opioid Analgesics Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Non-opioid Analgesics Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Non-opioid Analgesics Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Non-opioid Analgesics Manufacturing Cost Structure
Figure 45. Non-opioid Analgesics Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries